Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 32.03% is in line with its 5-year average of 29.95%, near the high end of its 5-year range (20.81%–34.98%).
0.79% below its 12-month average of 32.29%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
32.03%
OPERATING MARGIN AVG TTM
32.29%
OPERATING MARGIN AVG 3Y
30.59%
OPERATING MARGIN AVG 5Y
29.95%
OPERATING MARGIN AVG 10Y
26.33%
OPERATING MARGIN AVG 15Y
23.92%
OPERATING MARGIN AVG 20Y
22.20%
CURRENT VS TTM AVG
-0.79%
CURRENT VS 3Y AVG
+4.71%
CURRENT VS 5Y AVG
+6.94%
CURRENT VS 10Y AVG
+21.63%
CURRENT VS 15Y AVG
+33.89%
CURRENT VS 20Y AVG
+44.25%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+114.97%
vs the sector median at left
IDEXX Laboratories, Inc.
Market Cap
$41.09B
Operating Margin
32.03%
TTM Avg
32.29%
3Y Avg
30.59%
5Y Avg
29.95%
Market Cap
$40.75B
Operating Margin
22.23%
TTM Avg
22.07%
3Y Avg
21.88%
5Y Avg
20.79%
Market Cap
$42.00B
Operating Margin
13.57%
TTM Avg
14.15%
3Y Avg
13.50%
5Y Avg
11.74%
Market Cap
$42.85B
Operating Margin
11.45%
TTM Avg
5.33%
3Y Avg
-0.33%
5Y Avg
-1.99%
Market Cap
$34.25B
Operating Margin
20.81%
TTM Avg
2.82%
3Y Avg
-21.37%
5Y Avg
-56.25%
Market Cap
$49.69B
Operating Margin
9.83%
TTM Avg
11.84%
3Y Avg
11.67%
5Y Avg
10.68%
Market Cap
$49.91B
Operating Margin
28.09%
TTM Avg
26.16%
3Y Avg
28.11%
5Y Avg
28.79%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $41.09B | 32.03% | 32.29% | 30.59% | 29.95% |
| Agilent Technologies, Inc. (A)vs › | $40.75B | 22.23% | 22.07% | 21.88% | 20.79% |
| IQVIA Holdings Inc. (IQV)vs › | $42.00B | 13.57% | 14.15% | 13.50% | 11.74% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.85B | 11.45% | 5.33% | -0.33% | -1.99% |
| Humana Inc. (HUM)vs › | $47.86B | 1.39% | 1.25% | 2.37% | 3.27% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.25B | 20.81% | 2.82% | -21.37% | -56.25% |
| Alcon Inc. (ALC)vs › | $33.61B | 9.87% | 13.67% | 11.51% | 7.66% |
| Becton, Dickinson and Company (BDX)vs › | $49.69B | 9.83% | 11.84% | 11.67% | 10.68% |
| Edwards Lifesciences Corporation (EW)vs › | $49.91B | 28.09% | 26.16% | 28.11% | 28.79% |
| DexCom, Inc. (DXCM)vs › | $32.00B | 22.92% | 17.22% | 16.09% | 15.13% |
Gross Margin
62.5%
Operating Margin
32.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 34.98% |
| 2026-03-31 | 31.78% |
| 2025-12-31 | 28.94% |
| 2025-09-30 | 32.11% |
| 2025-06-30 | 33.62% |
| 2025-03-31 | 31.70% |
| 2024-12-31 | 27.42% |
| 2024-09-30 | 31.15% |
| 2024-06-30 | 26.29% |
| 2024-03-31 | 31.01% |
| 2023-12-31 | 27.21% |
| 2023-09-30 | 30.07% |
| 2023-06-30 | 31.38% |
| 2023-03-31 | 31.15% |
| 2022-12-31 | 27.34% |
| 2022-09-30 | 29.09% |
| 2022-06-30 | 20.81% |
| 2022-03-31 | 29.69% |
| 2021-12-31 | 24.86% |
| 2021-09-30 | 27.88% |
| 2021-06-30 | 31.38% |
| 2021-03-31 | 31.84% |
| 2020-12-31 | 25.67% |
| 2020-09-30 | 23.81% |
| 2020-06-30 | 30.31% |
| 2020-03-31 | 23.04% |
| 2019-12-31 | 19.10% |
| 2019-09-30 | 23.10% |
| 2019-06-30 | 26.49% |
| 2019-03-31 | 23.11% |
| 2018-12-31 | 21.00% |
| 2018-09-30 | 21.51% |
| 2018-06-30 | 25.07% |
| 2018-03-31 | 21.03% |
| 2017-12-31 | 19.33% |
| 2017-09-30 | 20.41% |
| 2017-06-30 | 24.08% |
| 2017-03-31 | 19.97% |
| 2016-12-31 | 18.92% |
| 2016-09-30 | 19.73% |
| 2016-06-30 | 22.33% |
| 2016-03-31 | 17.67% |
| 2015-12-31 | 16.74% |
| 2015-09-30 | 17.69% |
| 2015-06-30 | 21.36% |
| 2015-03-31 | 19.03% |
| 2014-12-31 | 9.89% |
| 2014-09-30 | 18.82% |
| 2014-06-30 | 21.33% |
| 2014-03-31 | 19.45% |
| 2013-12-31 | 17.32% |
| 2013-09-30 | 19.36% |
| 2013-06-30 | 22.34% |
| 2013-03-31 | 18.42% |
| 2012-12-31 | 19.85% |
| 2012-09-30 | 19.94% |
| 2012-06-30 | 22.59% |
| 2012-03-31 | 18.72% |
| 2011-12-31 | 18.00% |
| 2011-09-30 | 18.64% |
| 2011-06-30 | 22.43% |
| 2011-03-31 | 18.29% |
| 2010-12-31 | 17.90% |
| 2010-09-30 | 18.48% |
| 2010-06-30 | 19.48% |
| 2010-03-31 | 18.03% |
| 2009-12-31 | 16.33% |
| 2009-09-30 | 17.06% |
| 2009-06-30 | 18.51% |
| 2009-03-31 | 16.26% |
| 2008-12-31 | 14.73% |
| 2008-09-30 | 15.53% |
| 2008-06-30 | 20.99% |
| 2008-03-31 | 15.55% |
| 2007-12-31 | 15.00% |
| 2007-09-30 | 15.74% |
| 2007-06-30 | 13.70% |
| 2007-03-31 | 14.62% |
| 2006-12-31 | 15.33% |
| 2006-09-30 | 18.39% |
| 2006-06-30 | 19.35% |
| 2006-03-31 | 16.04% |
| 2005-12-31 | 18.08% |
| 2005-09-30 | 19.06% |
| 2005-06-30 | 17.98% |
| 2005-03-31 | 17.15% |
| 2004-12-31 | 16.13% |
| 2004-09-30 | 21.18% |
| 2004-06-30 | 22.61% |
| 2004-03-31 | 18.96% |
| 2003-12-31 | 12.27% |
| 2003-09-30 | 19.40% |
| 2003-06-30 | 19.97% |
| 2003-03-31 | 15.97% |
| 2002-12-31 | 17.47% |
| 2002-09-30 | 17.51% |
